GLP-1 RAs are recommended in the treatment guidelines by the American Diabetes Association as well as the American Association of Clinical Endocrinology (AACE) Consensus Statement & European Society of Cardiology for type 2 diabetes mellitus patients with co-morbidities, like established atherosclerotic cardiovascular disease and obesity
Additionally, a rating of each study based upon the number of subjects studied, time interval of testing, dosing, technical parameters that were quantified, etc
Studies have shown that Akkermansia might: Increase GLP-1 secretion: This friendly bacteria may interact with your gut lining to stimulate the release of GLP-1, promoting feelings of fullness and fat burning
The evaluation is free, and it is where your provider sets your starting dose and reviews the program with you
But overall, participants on GLP-1 drugs experienced fewer sight-threatening complications related to their diabetic retinopathy and required less invasive eye treatments compared to the group taking other diabetes medications
The IGB + semaglutide group lost more weight than the IGB only group at 3, 6, and 12 months, with statistically significant differences at 6 months (29.09 3.45 kg vs